Keratoderma blennorrhagica.

Coelho I, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-222475 Description A 26-year-old woman, previously healthy, that a month ago started complaining of pain in the soles of both feet, which followed, additionally, to the right knee, the left knee, left elbow and right shoulder. She reported morning stiffness exceeding 1 hour that decreased with physical activity, worsened with rest, but improved with administration of non-steroidal anti-inflammatory drugs (NSAIDs). Three weeks later, skin lesions appeared on the soles of the feet. Seven to 8 weeks before, the patient would have had two successive episodes of a urinary tract infection, treated, respectively, with fosfomycin and ciprofloxacin. The patient did not present gastrointestinal symptoms, previous weight loss or sweating. On physical exam , it was verified pain at knee mobilisation, more intense in the left, where it presented articular effusion. The cutaneous lesions were about 0.5 cm in diameter, were maculopapular, on a background of diffuse erythema and of desquamation on large blades (figure 1); no other skin lesions were observed. Microbial examinations, including urine culture, blood cultures, urethral swab and synovial fluid, were negative. The research of Chlamydia trachomatis, Ureaplasma urealyticum, Gonococcus and Treponema pallidum by PCR did not document previous infection. Analyzing the remaining tests, it was found to be positive for the human leucocyte antigen (HLA)-B27. It was concluded that the most likely diagnosis was reactive arthritis (ReA) or Reiter's arthritis, whereby the patient was treated with doxycycline and rifampicin for 3 months in association with sulfasalazine and the remaining symptomatic treatment with NSAIDs. Complete resolution of skin complaints and lesions was verified 1 month after the diagnosis, and in the follow-up, there were no new symptomatic complaints or cutaneous lesions that might suggest other differential diagnoses, namely, psoriatic arthritis. ReA is a spondyloarthropathy resulting from cross-reactivity antigens, usually triggered by gastrointestinal or genitourinary infections, most often by C. trachomatis, Yersinia or Salmonella. It is characterised by musculoskeletal attainment, being able to reach several joints, more frequently knees and ankles. It may be associated with ocular and cutaneous manifestations, such as balanitis circinata or, less frequently, blennorrhagic keratoderma. 3 The diagnosis of ReA is presumptive and based on clinical features, namely by the correlation between recent genitourinary or gastrointestinal infections, asymmetric oligoarthritis and other possible extra-articular manifestations, such as enthesopathy or ocular inflammation. The acknowledgement of the dermatological picture of blennorrhagic keratoderma in an appropriate clinical setting greatly facilitates proper diagnosis and treatment. The presence of HLA-B27, in addition to increasing susceptibility, seems to be associated with more severe forms and chronic evolution. The use of antibiotic therapy should be considered when there is evidence of infection, and its efficacy depends on the causal agent of the disease. Enteric infection treatment is only indicated in the presence of active infection, with the most suitable drugs being ciprofloxacin or sulfamethoxazole– trimethoprim. In patients with genitourinary tract infection, the use of tetracycline or derivatives and the treatment of sexual partners are essential to prevent reinfestation. As urogenital Chlamydia infection is often asymptomatic, it is prudent to investigate patients with diagnosis of ReA with no defined causal factor.